AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+38.79%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$4.14B
AUM Growth
+$4.14B
(+25%)
Cap. Flow
+$72.5M
Cap. Flow
% of AUM
1.75%
Top 10 Holdings %
Top 10 Hldgs %
92.37%
Holding
74
New
9
Increased
9
Reduced
10
Closed
3
Top Buys
| 1 |
MBLY
Mobileye N.V.
MBLY
|
$14.8M |
| 2 |
Visa
V
|
$13.6M |
| 3 |
JPMorgan Chase
JPM
|
$13.2M |
| 4 |
CELG
Celgene Corp
CELG
|
$12M |
| 5 |
Yum! Brands
YUM
|
$11M |
Top Sells
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$17.3M |
| 2 |
Bank of America
BAC
|
$15.6M |
| 3 |
LNKD
LinkedIn Corporation
LNKD
|
$5.63M |
| 4 |
Nektar Therapeutics
NKTR
|
$3.37M |
| 5 |
Ionis Pharmaceuticals
IONS
|
$3.1M |
Sector Composition
| 1 | Consumer Staples | 51.92% |
| 2 | Healthcare | 25.71% |
| 3 | Consumer Discretionary | 17.85% |
| 4 | Financials | 1.87% |
| 5 | Technology | 0.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BUFF
1
DELISTED
Blue Buffalo Pet Products, Inc
BUFF
| $2.15B | 40.39% | 114,987,547 | – | – |
|
2
Lexicon Pharmaceuticals
LXRX
$400M
| $766M | 14.37% | 57,517,977 -1 | -0% | -$13 |
|
|
WW
3
DELISTED
WW International
WW
| $671M | 12.6% | 29,443,300 | – | – |
|
4
Incyte
INCY
$16.5B
| $61.8M | 1.16% | 570,000 +80,000 | +16% | +$8.68M |
|
5
Alnylam Pharmaceuticals
ALNY
$58.5B
| $44.7M | 0.84% | 475,000 +40,000 | +9% | +$3.77M |
|
6
Mastercard
MA
$538B
| $29.2M | 0.55% | 300,000 | – | – |
|
|
7
BioMarin Pharmaceuticals
BMRN
$11.2B
| $28.8M | 0.54% | 275,000 -165,000 | -38% | -$17.3M |
|
|
8
Nektar Therapeutics
NKTR
$568M
| $27M | 0.51% | 1,600,000 -200,000 | -11% | -$3.37M |
|
9
Alibaba
BABA
$322B
| $24.4M | 0.46% | 300,000 | – | – |
|
|
BLUE
10
DELISTED
bluebird bio
BLUE
| $23.1M | 0.43% | 360,000 +45,000 | +14% | +$2.89M |
|
|
LNKD
11
DELISTED
LinkedIn Corporation
LNKD
| $22.5M | 0.42% | 100,000 -25,000 | -20% | -$5.63M |
|
|
12
Yum! Brands
YUM
$40.8B
| $21.9M | 0.41% | 300,000 +150,000 | +100% | +$11M |
|
|
13
Ionis Pharmaceuticals
IONS
$6.79B
| $21.7M | 0.41% | 350,000 -50,000 | -13% | -$3.1M |
|
|
KITE
14
DELISTED
Kite Pharma, Inc.
KITE
| $21.6M | 0.4% | 350,000 -40,000 | -10% | -$2.46M |
|
15
Agios Pharmaceuticals
AGIO
$2.19B
| $17.9M | 0.34% | 275,000 +50,000 | +22% | +$3.25M |
|
|
ARRY
16
DELISTED
Array Biopharma Inc
ARRY
| $15.7M | 0.29% | 3,710,000 | – | – |
|
|
MBLY
17
DELISTED
Mobileye N.V.
MBLY
| $14.8M | 0.28% | +350,000 | New | +$14.8M |
|
18
General Motors
GM
$55.8B
| $13.6M | 0.26% | 400,000 -50,000 | -11% | -$1.7M |
|
|
19
Visa
V
$683B
| $13.6M | 0.25% | +175,000 | New | +$13.6M |
|
|
20
JPMorgan Chase
JPM
$829B
| $13.2M | 0.25% | +200,000 | New | +$13.2M |
|
|
CELG
21
DELISTED
Celgene Corp
CELG
| $12M | 0.22% | +100,000 | New | +$12M |
|
22
LendingClub
LC
$1.97B
| $11.9M | 0.22% | 1,075,000 -100,000 | -9% | -$1.11M |
|
23
Morgan Stanley
MS
$240B
| $9.54M | 0.18% | 300,000 +50,000 | +20% | +$1.59M |
|
24
Aptiv
APTV
$17.3B
| $8.57M | 0.16% | +100,000 | New | +$8.57M |
|
|
JUNO
25
DELISTED
Juno Therapeutics, Inc.
JUNO
| $8.35M | 0.16% | 190,000 -45,000 | -19% | -$1.98M |
|